Corynebacterium amycolatum: Difference between revisions
From IDWiki
Corynebacterium amycolatum
No edit summary |
mNo edit summary |
||
Line 8: | Line 8: | ||
== Management == |
== Management == |
||
* Most reliably susceptible to [[vancomycin]], [[linezolid]], and [[quinupristin-dalfopristin]]; not reliably susceptible to [[penicillins]], [[cephalosporins]], or [[carbapenems]] |
* Most reliably susceptible to [[vancomycin]], [[linezolid]], and [[quinupristin-dalfopristin]]; not reliably susceptible to [[penicillins]], [[cephalosporins]], or [[carbapenems]][[CiteRef::zalas2004an]][[CiteRef::sengupta2015co]] |
||
[[Category:Gram-positive bacilli]] |
[[Category:Gram-positive bacilli]] |
Latest revision as of 17:36, 19 September 2024
Background
- Gram-positive bacilli within the genus Corynebacterium
- Rare cause of opportunistic infections
Management
- Most reliably susceptible to vancomycin, linezolid, and quinupristin-dalfopristin; not reliably susceptible to penicillins, cephalosporins, or carbapenems12
References
- ^ Zalas P, Mikucka A, Gospodarek E. [Antibiotic sensitivity of Corynebacterium amycolatum].. Medycyna doswiadczalna i mikrobiologia. 2004;56(4):327-34. PMID 15959988.
- ^ Mallika Sengupta. Corynebacterium amycolatum : An Unexpected Pathogen in the Ear. Journal of Clinical and Diagnostic Research. 2015. doi:10.7860/jcdr/2015/15134.7002.